John P. Butler insider trades

Open-market stock purchases and sales by John P. Butler, CEO and President at Akebia Therapeutics, Inc, from SEC Form 4 filings since Nov 14, 2013.

Track record: 0% of 7 scored buys are up 5% or more since purchase, averaging -81%.

Recent trades

DateStockTradeValue
Aug 6, 2026AKBA Akebia Therapeutics, IncBought (not open market)—
Mar 4, 2026AKBA Akebia Therapeutics, IncBought$86.6K
Feb 2, 2026AKBA Akebia Therapeutics, IncSold$64.9K
Feb 2, 2026AKBA Akebia Therapeutics, IncBought (not open market)$247K
Feb 2, 2026AKBA Akebia Therapeutics, IncSold$116K
Feb 2, 2026AKBA Akebia Therapeutics, IncSold$134K
Feb 2, 2026AKBA Akebia Therapeutics, IncSold$160K
Jan 30, 2026AKBA Akebia Therapeutics, IncBought (not open market)—
Jan 30, 2026AKBA Akebia Therapeutics, IncBought (not open market)—

Companies traded

  • AKBA Akebia Therapeutics, Inc: 7 buys, 21 sales, last Aug 6, 2026
  • ZYNE Zynerba Pharmaceuticals, Inc: 1 buy, 2 sales, last Oct 10, 2023
  • KERX Keryx Biopharmaceuticals Inc: other filings, last Jun 9, 2017
  • RLYP Relypsa Inc: 2 sales, last Sep 1, 2016

Get free alerts when John P. Butler files a new trade →